Medical Weight Loss for Anchorage, Alaska Residents
Anchorage, Alaska residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Anchorage through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Anchorage Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Anchorage, Alaska residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Anchorage is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Anchorage address.
Anchorage is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout Downtown, Midtown, South Anchorage, Spenard, the Hillside, and Eagle River. There is no distance surcharge for Anchorage patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Like much of Alaska, many people in Anchorage want a physician-supervised weight-loss option without local waitlists or unclear pricing. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Anchorage patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Anchorage
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Anchorage address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Anchorage
How do I get treatment from Anchorage?
As a Anchorage, Alaska patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Anchorage?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Anchorage in cold-pack packaging, no lines and no drive.
How much does it cost for Anchorage patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Anchorage do you serve?
We serve patients from across Anchorage by telehealth, including Downtown, Midtown, South Anchorage, Spenard, the Hillside, and Eagle River.
Is telehealth treatment as thorough as an in-person visit for Anchorage patients?
Yes. Anchorage patients get the same physician review by Dr. Sharma, the same contraindication screening, the same dose titration, and the same health-advisor support as any patient. Everything except a physical exam is handled by secure video, and compounded medication ships to your door. Telehealth eligibility is confirmed during the consultation.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Anchorage, Alaska by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.